Advisory Advocates »

Amgen shares owned by Advisory Advocates

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Advisory Advocates from 13F filings

Historical chart of Advisory Advocates investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Advisory Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Advisory Advocates

Quarter filed Position value Share count Share price at filing
2026-03-31 $845k 2.4k 351.86
2025-12-31 $941k 2.9k 327.32

More positions owned by Advisory Advocates

First Tr Exch Traded Fd Iii Ft Vest Smid (SDVD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Nuveen Equity Premium and Growth Fund (SPXX)
First Tr Exchange-traded Ft Vest Ris (RDVI)
Cohen & Steers infrastucture Fund (UTF)
Columbia Seligm Prem Tech Gr (STK)
Apple (AAPL)
Adams Express Company (ADX)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Eaton Vance Tax Managed Buy Write Opport (ETV)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vanguard World Inf Tech Etf (VGT)
Royce Value Trust (RVT)
Amazon (AMZN)

View all positions for Advisory Advocates

Top funds holding Amgen

Vanguard Group
BlackRock
Vanguard Capital Management
State Street Corporation
Capital World Investors
Morgan Stanley
Geode Capital Management
Vanguard Portfolio Management
Charles Schwab Investment Management
PRIMECAP Management Company
Capital Research and Management Company - Division 3
Wells Fargo & Company
Capital Research Global Investors
Northern Trust
Bank of America Corporation

View all funds holding Amgen